Dai Ichi Life Insurance Company, LTD Moderna, Inc. Transaction History

Dai Ichi Life Insurance Company, LTD

  • $3.9 Billion
  • Q3 2024

A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 7,673 shares of MRNA stock, worth $282,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,673
Previous 7,673 -0.0%
Holding current value
$282,750
Previous $911,000 43.8%
% of portfolio
0.01%
Previous 0.02%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$101.21 - $166.61 $506,049 - $833,050
5,000 Added 187.06%
7,673 $911,000
Q4 2023

Feb 09, 2024
SELL
$69.51 - $104.43 $903,630 - $1.36 Million
-13,000 Reduced 82.95%
2,673 $266,000
Q2 2023

Aug 11, 2023
SELL
$118.5 - $160.53 $25,833 - $34,995
-218 Reduced 1.37%
15,673 $1.9 Million
Q4 2022

Feb 14, 2023
BUY
$118.38 - $210.04 $317,021 - $562,487
2,678 Added 20.27%
15,891 $2.85 Million
Q1 2022

May 13, 2022
SELL
$126.46 - $235.05 $1.26 Million - $2.35 Million
-10,000 Reduced 43.08%
13,213 $2.28 Million
Q4 2021

Feb 11, 2022
BUY
$225.82 - $368.51 $2.71 Million - $4.42 Million
12,000 Added 107.02%
23,213 $5.9 Million
Q3 2021

Nov 04, 2021
BUY
$221.9 - $484.47 $17,752 - $38,757
80 Added 0.72%
11,213 $4.32 Million
Q4 2020

Feb 11, 2021
SELL
$65.74 - $169.86 $657,400 - $1.7 Million
-10,000 Reduced 47.32%
11,133 $1.16 Million
Q3 2020

Nov 12, 2020
SELL
$54.34 - $94.85 $18,529 - $32,343
-341 Reduced 1.59%
21,133 $1.5 Million
Q2 2020

Aug 12, 2020
BUY
$29.67 - $80.0 $637,133 - $1.72 Million
21,474 New
21,474 $1.38 Million

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email